Besthof Robert 4
4 · NRX Pharmaceuticals, Inc. · Filed Mar 10, 2022
Insider Transaction Report
Form 4
Besthof Robert
Chief Comm. & Patient Officer
Transactions
- Award
Employee Stock Option
2022-03-08$2.61/sh+100,000$261,000→ 347,200 totalExercise: $2.61Exp: 2032-03-08→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Options issued under the NRX Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan. The options vest on March 8, 2023, generally subject to the Reporting Person's continued service for NRX Pharmaceuticals, Inc.